Sea Separation Medical RIVAROXABAN correction solution and quality control liquid - Taiwan Registration ebf607d468cb69b2f5fd40b46a9f755c
Access comprehensive regulatory information for Sea Separation Medical RIVAROXABAN correction solution and quality control liquid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ebf607d468cb69b2f5fd40b46a9f755c and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is suitable for measuring the concentration of Rivaroxaban plasma sleeve and quality solution for correction, and is suitable for anti-Xa colorimetric analysis by titration method, suitable for Biophen DiXal set.
A Clinical chemistry and clinical toxicology
A.1150 calibration;; A.1660 Quality control materials (analytical and non-analytical)
import
Dates and Status
Dec 22, 2015
Dec 22, 2025